Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 20:24 UTC |
MacKinnon Alasdair JohnDirector
|
GrantCommon Stock | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084646 · tm2620760-3_4seq1.xml · nonDerivative · entry 1 MacKinnon Alasdair John · CIK 0002087967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,707 F1 · kind: The reported transaction involved the Reporting Person's receipt of 29,412 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Vuzix Corp. 2023 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting. The 29,412 RSUs shall vest on June 30, 2027, subject to the Reporting Person's continued service. F2 · balance_after: The total reported in Column 5 includes (i) the 29,412 newly awarded RSUs, of which 0 have vested and (ii) 65,295 restricted stock awards, of which 55,295 have vested. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:26 UTC |
Whitten-Doolin Paula BeckDirector
|
GrantCommon Stock | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084649 · tm2620760-2_4seq1.xml · nonDerivative · entry 1 Whitten-Doolin Paula Beck · CIK 0001951825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,080 F1 · kind: The reported transaction involved the Reporting Person's receipt of 29,412 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Vuzix Corp. 2023 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting. The 29,412 RSUs shall vest on June 30, 2027, subject to the Reporting Person's continued service. F2 · balance_after: The total reported in Column 5 includes (i) the 29,412 newly awarded RSUs, of which 0 have vested and (ii) 90,668 shares of common stock. Read SEC document |
| July 15, 2026 Filed Jul 20, 2026 12:03 UTC |
Harned Timothy HeydenreichDirector
|
GrantCommon Stock | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084892 · tm2620760-1_4seq1.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,570 F1 · kind: The reported transaction involved the Reporting Person's receipt of 29,412 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Vuzix Corp. 2023 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting. The 29,412 RSUs shall vest on June 30, 2027, subject to the Reporting Person's continued service. F2 · balance_after: The total reported in Column 5 includes (i) the 29,412 newly awarded RSUs, of which 0 have vested and (ii) 318,158 shares of common stock. Read SEC document |
| May 26, 2026 Filed May 27, 2026 20:05 UTC |
Whitten-Doolin Paula BeckDirector
|
SaleCommon Stock | 32,000 | $4.68 | $149,824.00 |
DisclosureSEC source: 0001104659-26-066913 · tm2615703-1_4seq1.xml · nonDerivative · entry 1 Whitten-Doolin Paula Beck · CIK 0001951825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,668 F1 · kind: The shares were sold to cover the reporting person's tax liability upon the vesting of equity compensation. F2 · price: This sales price reflects a weighted average of multiple prices ranging from $4.68 to $4.72. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request. Read SEC document |
| May 21, 2026 Filed May 21, 2026 21:53 UTC |
Harned Timothy HeydenreichDirector
|
SaleCommon Stock | 10,000 | $4.73 | $47,300.00 |
DisclosureSEC source: 0001104659-26-065277 · tm2615403-1_4seq1.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,158 F1 · kind: The shares were sold to cover the reporting person's tax liability upon the vesting of equity compensation. F2 · price: This sales price reflects a weighted average of multiple prices ranging from $4.69 to $4.75. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request. Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 18:48 UTC |
Russell GrantDirector · CFO
|
GrantRestricted Stock Unit · Derivative | 193,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-053240 · tm2613277-2_4seq1.xml · derivative · entry 1 Russell Grant · CIK 0001475058 · Director · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,258 Underlying: Common Stock · 193,258 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s), both time-based vesting and performance-based vesting, represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: 50% (96,629) of the RSUs will vest as follows: 1/3 each on December 15, 2026, 1/3 December 15, 2027, and 1/3 December 15, 2028. The remaining 50% (96,629) will vest solely upon certain performance achievements, up and until December 31, 2028, and not simply the passage of time. This latter 50% may increase up to 150% of such amount (144,943 RSUs) subject to certain bonus achievements. F2 · derivative.expiration_date: 50% (96,629) of the RSUs will vest as follows: 1/3 each on December 15, 2026, 1/3 December 15, 2027, and 1/3 December 15, 2028. The remaining 50% (96,629) will vest solely upon certain performance achievements, up and until December 31, 2028, and not simply the passage of time. This latter 50% may increase up to 150% of such amount (144,943 RSUs) subject to certain bonus achievements. Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 18:48 UTC |
Travers Paul JDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 477,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-053239 · tm2613277-1_4seq1.xml · derivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477,178 Underlying: Common Stock · 477,178 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s), both time-based vesting and performance-based vesting, represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: 50% (238,589) of the RSUs will vest as follows: 1/3 each on December 15, 2026, 1/3 December 15, 2027, and 1/3 December 15, 2028. The remaining 50% (238,589) will vest solely upon certain performance achievements, up and until December 31, 2028, and not simply the passage of time. This latter 50% may increase up to 150% of such amount (357,884 RSUs) subject to certain bonus achievements. F2 · derivative.expiration_date: 50% (238,589) of the RSUs will vest as follows: 1/3 each on December 15, 2026, 1/3 December 15, 2027, and 1/3 December 15, 2028. The remaining 50% (238,589) will vest solely upon certain performance achievements, up and until December 31, 2028, and not simply the passage of time. This latter 50% may increase up to 150% of such amount (357,884 RSUs) subject to certain bonus achievements. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:49 UTC |
Parkinson Christopher IainFormer officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-048768 · tm2612747-1_4seq1.xml · derivative · entry 1 Parkinson Christopher Iain · CIK 0002086540 · Former officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs would vest solely upon the achievement of certain revenue and EBITDA targets of the issuer's Enterprise Solutions business unit by December 31, 2028. F2 · derivative.expiration_date: The RSUs would vest solely upon the achievement of certain revenue and EBITDA targets of the issuer's Enterprise Solutions business unit by December 31, 2028. Read SEC document |
| March 04, 2026 Filed Mar 4, 2026 23:32 UTC |
Parkinson Christopher IainSee remarks
|
SaleCommon Stock | 11,663 | $2.69 | $31,367.64 |
DisclosureSEC source: 0001104659-26-023614 · tm268030-1_4seq1.xml · nonDerivative · entry 1 Parkinson Christopher Iain · CIK 0002086540 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,130 F1 · kind: The shares were sold to cover the reporting person's tax liability. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 22:21 UTC |
Parkinson Christopher IainSee Remarks
|
SaleCommon Stock | 9,457 | $2.92 | $27,614.44 |
DisclosureSEC source: 0001104659-25-124309 · tm2534274-1_4seq1.xml · nonDerivative · entry 1 Parkinson Christopher Iain · CIK 0002086540 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,793 F1 · kind: The shares were sold to cover the reporting person's tax liability. Read SEC document |
| September 29, 2025 Filed Sep 30, 2025 10:00 UTC |
Parkinson Christopher IainSee Remarks
|
GrantRestricted Stock Unit · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-094661 · tm2527455-1_4seq1.xml · derivative · entry 2 Parkinson Christopher Iain · CIK 0002086540 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F3 · derivative.exercise_date: The RSUs will vest solely upon the achievement of certain revenue and EBITDA targets of the issuer's Enterprise Solutions business unit by December 31, 2028. F3 · derivative.expiration_date: The RSUs will vest solely upon the achievement of certain revenue and EBITDA targets of the issuer's Enterprise Solutions business unit by December 31, 2028. Read SEC document |
| September 29, 2025 Filed Sep 30, 2025 10:00 UTC |
Parkinson Christopher IainSee Remarks
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-094661 · tm2527455-1_4seq1.xml · nonDerivative · entry 1 Parkinson Christopher Iain · CIK 0002086540 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,250 F1 · kind: Represents grant of restricted stock. The shares will vest quarterly over one year. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 13:44 UTC |
Quanta Computer Inc.10% owner
|
PurchaseSeries B Preferred Stock · Derivative | 230,242 | $21.72 Strike: $2.17 | $4,999,935.27 |
DisclosureSEC source: 0000950103-25-012007 · dp234645_4-quanta.xml · derivative · entry 1 Quanta Computer Inc. · CIK 0001427401 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,242 Underlying: Common Stock · 2,302,420 shares Expires not disclosed F1 · kind: On September 19, 2025, Quanta Computer Inc. ("Quanta") purchased 230,242 shares of the Issuer's Series B Preferred Stock at a purchase price of $21.716 per share under the third closing under the securities purchase agreement, dated September 3, 2024, between the Issuer and Quanta. Each share of Series B Preferred Stock is convertible into 10 shares of the Issuer's common stock. F1 · derivative.expiration_date: On September 19, 2025, Quanta Computer Inc. ("Quanta") purchased 230,242 shares of the Issuer's Series B Preferred Stock at a purchase price of $21.716 per share under the third closing under the securities purchase agreement, dated September 3, 2024, between the Issuer and Quanta. Each share of Series B Preferred Stock is convertible into 10 shares of the Issuer's common stock. Read SEC document |
| August 05, 2025 Filed Sep 25, 2025 21:15 UTC |
MacKinnon Alasdair JohnDirector
|
GrantCommon Stock | 65,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-093429 · tm2526910-2_4seq1.xml · nonDerivative · entry 1 MacKinnon Alasdair John · CIK 0002087967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,295 F1 · kind: Represents grant of restricted stock. 45,295 shares will vest on June 30, 2026, 10,000 shares will vest on June 30, 2026 and 10,000 shares will vest on June 30, 2027 Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:50 UTC |
Whitten-Doolin Paula BeckDirector
|
GrantCommon Stock | 31,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-065746 · tm2519859-3_4seq1.xml · nonDerivative · entry 1 Whitten-Doolin Paula Beck · CIK 0001951825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,668 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 14:20 UTC |
Kay Edward William Jr.Director
|
GrantCommon Stock | 31,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-065614 · tm2519859-1_4seq1.xml · nonDerivative · entry 1 Kay Edward William Jr. · CIK 0001562330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,511 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 14:17 UTC |
Harned Timothy HeydenreichDirector
|
GrantCommon Stock | 31,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-065611 · tm2519859-2_4seq1.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,158 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 19:10 UTC |
Quanta Computer Inc.10% owner
|
PurchaseSeries B Preferred Stock · Derivative | 189,717 | $26.35 Strike: $2.64 | $4,999,042.95 |
DisclosureSEC source: 0000950103-25-007511 · dp230296_4-qunata.xml · derivative · entry 1 Quanta Computer Inc. · CIK 0001427401 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,717 Underlying: Common Stock · 1,897,170 shares Expires not disclosed F1 · kind: On June 13, 2025, Quanta Computer Inc. ("Quanta") purchased 189,717 shares of the Issuer's Series B Preferred Stock at a purchase price of $26.35 per share under the second closing under the securities purchase agreement, dated September 3, 2024, between the Issuer and Quanta. Each share of Series B Preferred Stock is convertible into 10 shares of the Issuer's common stock. F1 · derivative.expiration_date: On June 13, 2025, Quanta Computer Inc. ("Quanta") purchased 189,717 shares of the Issuer's Series B Preferred Stock at a purchase price of $26.35 per share under the second closing under the securities purchase agreement, dated September 3, 2024, between the Issuer and Quanta. Each share of Series B Preferred Stock is convertible into 10 shares of the Issuer's common stock. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 23:49 UTC |
Jameson Peter HamiltonChief Operating Officer
|
OtherCommon Stock | 18,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-010188 · tm255741-1_4seq1.xml · nonDerivative · entry 1 Jameson Peter Hamilton · CIK 0001905276 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,575 F1 · kind: The shares were returned to the issuer for cancellation to cover the reporting person's tax liability. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:21 UTC |
Russell GrantDirector · CFO
|
OtherOptions (Right to Buy) · Derivative | 1,750,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001329 · tm252089-2_4seq1.xml · derivative · entry 2 Russell Grant · CIK 0001475058 · Director · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750,000 shares Expires 2033-03-17 F2 · kind: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. F3 · derivative.exercise_date: 125,000 options vested immediately, and the remainder were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. F3 · derivative.expiration_date: 125,000 options vested immediately, and the remainder were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:21 UTC |
Russell GrantDirector · CFO
|
GrantRestricted Stock Unit · Derivative | 118,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001329 · tm252089-2_4seq1.xml · derivative · entry 1 Russell Grant · CIK 0001475058 · Director · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,211 Underlying: Common Stock · 118,211 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. F2 · derivative.expiration_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:21 UTC |
Travers Paul JDirector · President and CEO
|
OtherOptions (Right to Buy) · Derivative | 3,260,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001327 · tm252089-1_4seq1.xml · derivative · entry 2 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,260,000 shares Expires 2031-03-17 F2 · kind: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. F3 · derivative.exercise_date: 250,000 options vested immediately, and the remainder were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. F3 · derivative.expiration_date: 250,000 options vested immediately, and the remainder were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:21 UTC |
Travers Paul JDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 291,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001327 · tm252089-1_4seq1.xml · derivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,878 Underlying: Common Stock · 291,878 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. F2 · derivative.expiration_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:48 UTC |
Jameson Peter HamiltonChief Operating Officer
|
OtherOptions (Right to Buy) · Derivative | 270,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001365 · tm252089-3_4seq1.xml · derivative · entry 2 Jameson Peter Hamilton · CIK 0001905276 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 270,000 shares Expires 2033-03-17 F2 · kind: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (55,821) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (55,821) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (69,776 RSUs) subject to achievement of certain results. F3 · derivative.exercise_date: The options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. F3 · derivative.expiration_date: The options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the options will terminate subject to and upon shareholder approval. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:48 UTC |
Jameson Peter HamiltonChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 111,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001365 · tm252089-3_4seq1.xml · derivative · entry 1 Jameson Peter Hamilton · CIK 0001905276 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,642 Underlying: Common Stock · 111,642 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (55,821) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (55,821) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (69,776 RSUs) subject to achievement of certain results. F2 · derivative.expiration_date: The RSUs and cancellation of the options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (55,821) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (55,821) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (69,776 RSUs) subject to achievement of certain results. Read SEC document |
| January 02, 2025 Filed Jan 8, 2025 16:34 UTC Amendment |
Russell GrantDirector · CFO
|
OtherOptions (Right to Buy) · Derivative | 1,625,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001104659-25-002060 · tm252669-2_4aseq1.xml · derivative · entry 2 Russell Grant · CIK 0001475058 · Director · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 1,750,000 shares Expires 2033-03-17 F2 · kind: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. F3 · derivative.exercise_date: 125,000 options vested immediately, and the remaining 1,625,000 options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the unvested options will terminate subject to and upon shareholder approval. F3 · derivative.expiration_date: 125,000 options vested immediately, and the remaining 1,625,000 options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the unvested options will terminate subject to and upon shareholder approval. Read SEC document |
| January 02, 2025 Filed Jan 8, 2025 16:34 UTC Amendment |
Russell GrantDirector · CFO
|
GrantRestricted Stock Unit · Derivative | 118,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-002060 · tm252669-2_4aseq1.xml · derivative · entry 1 Russell Grant · CIK 0001475058 · Director · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,211 Underlying: Common Stock · 118,211 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. F2 · derivative.expiration_date: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (59,105) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (59,105) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (73,881 RSUs) subject to achievement of certain results. Read SEC document |
| January 02, 2025 Filed Jan 8, 2025 16:33 UTC Amendment |
Travers Paul JDirector · President and CEO
|
OtherOptions (Right to Buy) · Derivative | 3,010,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001104659-25-002057 · tm252669-1_4aseq1.xml · derivative · entry 2 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 3,260,000 shares Expires 2031-03-17 F2 · kind: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. F3 · derivative.exercise_date: 250,000 options vested immediately, and the remaining 3,010,000 options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the unvested options will terminate subject to and upon shareholder approval. F3 · derivative.expiration_date: 250,000 options vested immediately, and the remaining 3,010,000 options were to vest solely upon achievement of certain market capitalization and operating results goals and not simply the passage of time. As set forth in footnote (2) above, the unvested options will terminate subject to and upon shareholder approval. Read SEC document |
| January 02, 2025 Filed Jan 8, 2025 16:33 UTC Amendment |
Travers Paul JDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 291,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-002057 · tm252669-1_4aseq1.xml · derivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,878 Underlying: Common Stock · 291,878 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. F2 · derivative.expiration_date: The RSUs and cancellation of the unvested options are subject to shareholder approval to be obtained at the Company's 2025 shareholder meeting. Upon and subject to such shareholder approval, the grant of the RSUs will be effective and the unvested options issued to the Reporting Person on March 17, 2021 will simultaneously terminate. Subject to the foregoing, 50% (145,939) of the RSUs will vest in 3 years from the date of grant, and the remaining 50% (145,939) will vest solely upon achievement of certain performance results goals and not simply the passage of time. This remaining 50% may increase to up to 125% of such amount (182,424 RSUs) subject to achievement of certain results. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 16:16 UTC |
Russell GrantDirector · CFO and Executive VP
|
GrantOption (right to buy) · Derivative | 310,023 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001104659-24-077355 · tm2418729-4_4seq1.xml · derivative · entry 1 Russell Grant · CIK 0001475058 · Director · CFO and Executive VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,023 Underlying: Common Stock · 310,023 shares Expires 2034-07-01 F1 · kind: Options were issued pursuant to the issuer's voluntary Company-wide payroll reduction program for a 12-month period. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 16:16 UTC |
Travers Paul JDirector · President and CEO
|
GrantOption (right to buy) · Derivative | 624,369 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001104659-24-077356 · tm2418729-5_4seq1.xml · derivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,369 Underlying: Common Stock · 624,369 shares Expires 2034-07-01 F1 · kind: Options were issued pursuant to the issuer's voluntary Company-wide payroll reduction program for a 12-month period. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:15 UTC |
Jameson Peter HamiltonChief Operating Officer
|
GrantOption (right to buy) · Derivative | 361,553 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001104659-24-077352 · tm2418729-3_4seq1.xml · derivative · entry 1 Jameson Peter Hamilton · CIK 0001905276 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,553 Underlying: Common Stock · 361,553 shares Expires 2034-07-01 F1 · kind: Options were issued pursuant to the issuer's voluntary Company-wide payroll reduction program for a 12-month period Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:14 UTC |
Kay Edward William Jr.Director
|
GrantStock Options (right to buy) · Derivative | 175,758 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001104659-24-077351 · tm2418729-2_4seq1.xml · derivative · entry 2 Kay Edward William Jr. · CIK 0001562330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,758 Underlying: Common Stock · 175,758 shares Expires 2034-07-01 F2 · kind: Represents an option award to the reporting person, which the reporting person elected to receive in lieu of certain cash compensation. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:14 UTC |
Kay Edward William Jr.Director
|
GrantCommon Stock | 70,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077351 · tm2418729-2_4seq1.xml · nonDerivative · entry 1 Kay Edward William Jr. · CIK 0001562330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,765 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC |
Harned Timothy HeydenreichDirector
|
GrantCommon Stock | 110,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077350 · tm2418729-1_4seq1.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,412 F1 · kind: Represents a stock award to the reporting person, including 39,474 shares the reporting person elected to receive in lieu of certain cash compensation. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| July 01, 2024 Filed Jul 10, 2024 00:17 UTC |
Whitten-Doolin Paula BeckDirector
|
GrantStock Options (right to buy) · Derivative | 40,404 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001104659-24-078701 · tm2419176-2_4seq1.xml · derivative · entry 2 Whitten-Doolin Paula Beck · CIK 0001951825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,404 Underlying: Common Stock · 40,404 shares Expires 2034-07-01 F2 · kind: Represents an option award to the reporting person, which the reporting person elected to receive in lieu of certain cash compensation. Read SEC document |
| July 01, 2024 Filed Jul 10, 2024 00:17 UTC |
Whitten-Doolin Paula BeckDirector
|
GrantCommon Stock | 90,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-078701 · tm2419176-2_4seq1.xml · nonDerivative · entry 1 Whitten-Doolin Paula Beck · CIK 0001951825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,922 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
| April 22, 2024 Filed Apr 22, 2024 12:40 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.25 | $3,125.00 |
DisclosureSEC source: 0001104659-24-049860 · tm2412378-1_4seq1.xml · nonDerivative · entry 5 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,859,670 F1 · ownership.direct: Following the final purchase reported hereunder, 1,989,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 22, 2024 Filed Apr 22, 2024 12:40 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.25 | $3,125.00 |
DisclosureSEC source: 0001104659-24-049860 · tm2412378-1_4seq1.xml · nonDerivative · entry 4 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,857,170 F1 · ownership.direct: Following the final purchase reported hereunder, 1,989,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 22, 2024 Filed Apr 22, 2024 12:40 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.23 | $3,073.25 |
DisclosureSEC source: 0001104659-24-049860 · tm2412378-1_4seq1.xml · nonDerivative · entry 3 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,854,670 F1 · ownership.direct: Following the final purchase reported hereunder, 1,989,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 22, 2024 Filed Apr 22, 2024 12:40 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $1.26 | $6,300.00 |
DisclosureSEC source: 0001104659-24-049860 · tm2412378-1_4seq1.xml · nonDerivative · entry 2 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,852,170 F1 · ownership.direct: Following the final purchase reported hereunder, 1,989,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 22, 2024 Filed Apr 22, 2024 12:40 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,000 | $1.27 | $2,539.80 |
DisclosureSEC source: 0001104659-24-049860 · tm2412378-1_4seq1.xml · nonDerivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,847,170 F1 · ownership.direct: Following the final purchase reported hereunder, 1,989,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 15:54 UTC |
Harned Timothy HeydenreichDirector
|
PurchaseCommon Stock | 20,000 | $1.31 | $26,188.00 |
DisclosureSEC source: 0001104659-24-050434 · tm2412497-1_4seq1.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,016 F1 · price: This sales price reflects a weighted average of multiple prices ranging from $1.275 to $1.335. Full information regarding the number of shares acquired at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request. Read SEC document |
| April 18, 2024 Filed Apr 18, 2024 13:50 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.34 | $3,349.75 |
DisclosureSEC source: 0001104659-24-048750 · tm2412195-1_4seq1.xml · nonDerivative · entry 3 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,845,170 F1 · ownership.direct: Following the final purchase reported hereunder, 1,975,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 18, 2024 Filed Apr 18, 2024 13:50 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.34 | $3,337.50 |
DisclosureSEC source: 0001104659-24-048750 · tm2412195-1_4seq1.xml · nonDerivative · entry 2 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,842,670 F1 · ownership.direct: Following the final purchase reported hereunder, 1,975,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 18, 2024 Filed Apr 18, 2024 13:50 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $1.35 | $3,375.00 |
DisclosureSEC source: 0001104659-24-048750 · tm2412195-1_4seq1.xml · nonDerivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,840,170 F1 · ownership.direct: Following the final purchase reported hereunder, 1,975,170 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 16:51 UTC |
Jameson Peter HamiltonChief Operating Officer
|
OtherCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-049866 · tm2412378-2_4seq1.xml · nonDerivative · entry 1 Jameson Peter Hamilton · CIK 0001905276 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,600 F1 · kind: The shares were returned to the issuer for cancellation to cover the reporting person's tax liability. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:35 UTC |
Travers Paul JDirector · President and CEO
|
PurchaseCommon Stock | 7,500 | $2.57 | $19,274.25 |
DisclosureSEC source: 0001104659-23-119333 · tm2330926-1_4seq1.xml · nonDerivative · entry 1 Travers Paul J · CIK 0001475077 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,837,670 F1 · ownership.direct: 1,967,670 shares are held directly by Mr. Travers and 870,000 shares are held by grantor retained annuity trusts as follows: 609,000 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust I dated May 14, 2015, 182,700 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust II dated May 14, 2015, and 78,300 shares by Serge Turcotte as trustee of the Paul Travers Annuity Trust III dated May 14, 2015. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 16:10 UTC |
Kay Edward William Jr.Director
|
PurchaseCommon Stock | 10,000 | $4.23 | $42,300.00 |
DisclosureSEC source: 0001104659-23-092925 · tm2324059d1_4seq1.xml · nonDerivative · entry 1 Kay Edward William Jr. · CIK 0001562330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,843 Read SEC document |
| July 10, 2023 Filed Jul 13, 2023 22:40 UTC |
Harned Timothy HeydenreichDirector
|
GrantCommon Stock | 19,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-080869 · tm2321260-3_4.xml · nonDerivative · entry 1 Harned Timothy Heydenreich · CIK 0001709813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,016 F1 · kind: Represents a stock award to the reporting person. The shares will vest at the one-year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.